119 related articles for article (PubMed ID: 618863)
41. The different forms of antithrombin II in serum.
Pepper DS; Banhegyi D; Cash JD
Thromb Haemost; 1977 Aug; 38(2):494-503. PubMed ID: 579491
[TBL] [Abstract][Full Text] [Related]
42. "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate.
Nayak RC; Omar MA; Rabizadeh A; Srikanta S; Eisenbarth GS
Diabetes; 1985 Jun; 34(6):617-9. PubMed ID: 2989050
[TBL] [Abstract][Full Text] [Related]
43. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
44. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
Peterson CB; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
[TBL] [Abstract][Full Text] [Related]
45. Antithrombin III: a backward glance o'er travel'd roads.
Seegers WH
Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
[TBL] [Abstract][Full Text] [Related]
46. The rate-determining step of the heparin-catalyzed antithrombin/thrombin reaction is independent of thrombin.
Pletcher CH; Nelsestuen GL
J Biol Chem; 1982 May; 257(10):5342-5. PubMed ID: 7068594
[TBL] [Abstract][Full Text] [Related]
47. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
[TBL] [Abstract][Full Text] [Related]
48. Purification and characterization of rat plasma antithrombin III.
Takahara H; Sinohara H
Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
[TBL] [Abstract][Full Text] [Related]
49. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
50. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
51. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
Pletcher CH; Cunningham MT; Nelsestuen GL
J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
[TBL] [Abstract][Full Text] [Related]
52. Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor.
Liu DY; Yu SF; Remold HG; David JR
Cell Immunol; 1985 Feb; 90(2):539-46. PubMed ID: 3917866
[TBL] [Abstract][Full Text] [Related]
53. The catalysis by heparin of the reaction between thrombin and antithrombin.
Evington JR; Feldman PA; Luscombe M; Holbrook JJ
Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
[TBL] [Abstract][Full Text] [Related]
54. Carbohydrate structure of glycopeptides isolated from an hepatic membrane-binding protein specific for asialoglycoproteins.
Kawasaki T; Ashwell G
J Biol Chem; 1976 Sep; 251(17):5292-9. PubMed ID: 956187
[TBL] [Abstract][Full Text] [Related]
55. Structural studies on the oligosaccharides of a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
Bhattacharyya SN; Lynn WS
J Biol Chem; 1977 Feb; 252(4):1172-80. PubMed ID: 838711
[TBL] [Abstract][Full Text] [Related]
56. Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
Grimmer O; Fagerhol MK
Int J Pept Protein Res; 1977; 9(2):85-90. PubMed ID: 402327
[TBL] [Abstract][Full Text] [Related]
57. Structural studies on bovine prothrombin. Isolation and partial characterization of the Ca2+ binding and carbohydrate containing peptides of the N-terminus region.
Benson BJ; Hanahan DJ
Biochemistry; 1975 Jul; 14(14):3265-77. PubMed ID: 1170888
[TBL] [Abstract][Full Text] [Related]
58. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
59. Chicken antithrombin. Isolation, characterization, and comparison with mammalian antithrombins and chicken ovalbumin.
Koide T; Ohta Y; Odani S; Ono T
J Biochem; 1982 Apr; 91(4):1223-9. PubMed ID: 6920385
[TBL] [Abstract][Full Text] [Related]
60. A new assay for the measurement of total progressive antithrombin.
Lane JL; Bird P; Rizza CR
Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
